Reuters logo
BRIEF-Merck announces results of REVEAL outcomes study of Anacetrapib
August 29, 2017 / 6:43 AM / 24 days ago

BRIEF-Merck announces results of REVEAL outcomes study of Anacetrapib

Aug 29 (Reuters) - Merck & Co Inc

* Merck announces results of REVEAL outcomes study of Anacetrapib, investigational medicine for cardiovascular disease

* Merck- reviewing results of trial with external experts,will consider whether to file new drug applications with U.S. FDA and other regulatory agencies

* The safety of Anacetrapib was generally consistent with data from earlier trials of the drug

* However, a sub-study also showed that Anacetrapib accumulates in adipose tissue with prolonged dosing Source text for Eikon: Further company coverage: ))

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below